Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebral small vessel disease burden and longitudinal cognitive decline from age 73 to 82: the Lothian Birth Cohort 1936.

Translational psychiatry·2021
Same author

Prioritisation of areas for early detection of southward movement of arctic fox rabies based on historical surveillance data in Quebec, Canada.

Epidemiology and infection·2020
Same author

Prevalence of antibiotic resistance and virulence genes in the biofilms from an aquifer recharged with stormwater.

Water research·2020
Same author

Scientific Business Abstracts of the 113th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

QJM : monthly journal of the Association of Physicians·2019
Same author

Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia.

Pilot and feasibility studies·2018

Related Experiment Video

Updated: May 14, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

A PheWAS approach in studying HLA-DRB1*1501.

S J Hebbring1, S J Schrodi, Z Ye

  • 1Department of Center for Human Genetics, Marshfield Clinic Research Foundation, Marshfield, WI, USA. hebbring.scott@mcrf.mfldclin.edu

Genes and Immunity
|February 9, 2013
PubMed
Summary
This summary is machine-generated.

The HLA-DRB1*1501 genetic variant, linked to multiple sclerosis (MS), was also strongly associated with alcohol-induced liver cirrhosis in a large-scale phenome-wide association study (PheWAS). This research highlights novel associations and validates the PheWAS approach.

More Related Videos

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Related Experiment Videos

Last Updated: May 14, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Area of Science:

  • Genetics
  • Immunology
  • Computational Biology

Background:

  • The Human Leukocyte Antigen (HLA) complex plays a crucial role in immune responses.
  • Genetic variations within the HLA-DRB1 gene are implicated in various autoimmune diseases.
  • The HLA-DRB1*1501 haplotype is a known risk factor for multiple sclerosis (MS).

Purpose of the Study:

  • To investigate the association of the rs3135388 genotype, which tags the HLA-DRB1*1501 haplotype, with a wide range of health phenotypes.
  • To validate the utility and feasibility of the phenome-wide association study (PheWAS) approach using external data.
  • To explore potential novel associations of the HLA-DRB1*1501 locus beyond known autoimmune links.

Main Methods:

  • A phenome-wide association study (PheWAS) was conducted using electronic health records from 4235 individuals.
  • The study analyzed the association between the rs3135388 genotype (tagging HLA-DRB1*1501) and 4841 distinct phenotypes.
  • Statistical analyses were performed to identify significant genotype-phenotype associations, including those for multiple sclerosis and other conditions.

Main Results:

  • The expected association between HLA-DRB1*1501 and multiple sclerosis (ICD9 340) was confirmed (P=0.023).
  • The strongest association identified was between HLA-DRB1*1501 and alcohol-induced cirrhosis of the liver (ICD9 571.2, P=0.00011).
  • Additional significant associations were found with erythematous conditions (ICD9 695, P=0.0054) and benign respiratory neoplasms (ICD9 212, P=0.042).

Conclusions:

  • The study successfully validated the PheWAS approach as a powerful tool for genetic discovery.
  • The findings reveal a significant association between the HLA-DRB1*1501 locus and alcohol-induced liver cirrhosis, suggesting a broader role beyond autoimmunity.
  • This research underscores the complex genetic underpinnings of the HLA-DRB1*1501 locus and its potential involvement in diverse pathologies.